Search

Your search keyword '"Morra, Enrica"' showing total 532 results

Search Constraints

Start Over You searched for: Author "Morra, Enrica" Remove constraint Author: "Morra, Enrica" Language english Remove constraint Language: english
532 results on '"Morra, Enrica"'

Search Results

1. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

2. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

3. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

4. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

5. The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”

6. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

13. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

20. Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia

22. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

25. Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: A retrospective analysis of the Rete Ematologica Lombarda

26. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma

30. Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups

40. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

43. Splenic marginal zone lymphoma: a prognostic model for clinical use

44. Update on treatment recommendations from the Third International Workshop on Waldenström's Macroglobulinemia

46. Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia

47. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

48. Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia: An Effective but Myelosuppressive Regimen to be Offered to Patients With Advanced Disease

49. Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

Catalog

Books, media, physical & digital resources